The vector of anti-Biotin chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human Biotin. The T cells are genetically modified through transduction with a lentiviral vector expressing mcAv/dcAv antibody linked to CD3-zeta signaling domains. And the vector product was designed for the treatment of cancer.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-T-2-M400-CZ||Biotin h(b2c-CD3ζ) CAR, [T]|
|CAR-T-2-M400-4Z||Biotin h(CD4-CD3ζ) CAR, [T]|
|CAR-T-2-M400-2G||Biotin h(CD28-FcεRIγ) CAR, [T]|
|CAR-T-3-M400-2XZ||Biotin h(CD28-OX40-CD3ζ) CAR, [T]|
|CAR-T-2-M400-2Z||Biotin h(CD28-CD3ζ) CAR, [T]|
|CAR-T-3-M400-2BZ||Biotin h(CD28-41BB-CD3ζ) CAR, [T]|
|CAR-T-1-M400-G||Biotin h(FcεRIγ) CAR, [T]|
|CAR-T-2-M400-8Z||Biotin h(CD8-CD3ζ) CAR, [T]|
|CAR-T-2-M400-4G||Biotin h(CD4-FcεRIγ) CAR, [T]|
|CAR-T-1-M400-2||Biotin h(CD28) CAR, [T]|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved